Stephen Crocker

Dr. Stephen Crocker


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ANAlexandra M. Nicaise
Alexandra M. Nicaise
LWLaura J. Wagstaff
Laura J. Wagstaff
CWCory M. Willis
Cory M. Willis
CPCarolyn Paisie
Carolyn Paisie
HCHarshpreet Chandok
Harshpreet Chandok
SCStephen Crocker
Stephen Crocker
Cellular senescence is a form of adaptive cellular physiology associated with aging. Cellular senescence causes a proinflammatory cellular phenotype that impairs tissue regeneration, has been linked to stress, and is implicated in several human neurodegenerative diseases. We had previously determined that neural progenitor cells (NPCs) derived from induced pluripotent stem cell (iPSC) lines from patients with primary progressive multiple sclerosis (PPMS) failed to promote oligodendrocyte progenitor cell (OPC) maturation, whereas NPCs from age-matched control cell lines did so efficiently. Herein, we report that expression of hallmarks of cellular senescence were identified in SOX2 + progenitor cells within white matter lesions of human progressive MS (PMS) autopsy brain tissues and iPS-derived NPCs from patients with PPMS. Expression of cellular senescence genes in PPMS NPCs was found to be reversible by treatment with rapamycin, which then enhanced PPMS NPC support for oligodendrocyte (OL) differentiation. A proteomic analysis of the PPMS NPC secretome identified high-mobility group box-1 (HMGB1), which was found to be a senescence-associated inhibitor of OL differentiation. Transcriptome analysis of OPCs revealed that senescent NPCs induced expression of epigenetic regulators mediated by extracellular HMGB1. Lastly, we determined that progenitor cells are a source of elevated HMGB1 in human white matter lesions. Based on these data, we conclude that cellular senescence contributes to altered progenitor cell functions in demyelinated lesions in MS. Moreover, these data implicate cellular aging and senescence as a process that contributes to remyelination failure in PMS, which may impact how this disease is modeled and inform development of future myelin regeneration strategies.

20 September 2010 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
CMCraig S. Moore
Craig S. Moore
SAShahana L. Abdullah
Shahana L. Abdullah
ABAndrew Brown
Andrew Brown
AAAmanda Arulpragasam
Amanda Arulpragasam
SCStephen Crocker
Stephen Crocker

20 April 2011 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
CMCraig S. Moore
Craig S. Moore
RMRichard Milner
Richard Milner
ANAkiko Nishiyama
Akiko Nishiyama
RFRicardo F. Frausto
Ricardo F. Frausto
DSDavid R. Serwanski
David R. Serwanski
SCStephen Crocker
Stephen Crocker
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an extracellular protein and endogenous regulator of matrix metalloproteinases (MMPs) secreted by astrocytes in response to CNS myelin injury. We have previously reported that adult TIMP-1 knock-out (KO) mice exhibit poor myelin repair following demyelinating injury. This observation led us to hypothesize a role for TIMP-1 in oligodendrogenesis and CNS myelination. Herein, we demonstrate that compact myelin formation is significantly delayed in TIMP-1 KO mice, a situation that coincided with dramatically reduced numbers of white matter astrocytes in the developing CNS. Analysis of differentiation in CNS progenitor cells (neurosphere) cultures from TIMP-1 KO mice revealed a specific deficit of NG2+oligodendrocyte progenitor cells. Application of recombinant murine TIMP-1 (rmTIMP-1) to TIMP-1 KO neurosphere cultures evoked a dose-dependent increase in NG2+cell numbers, while treatment with GM6001, a potent broad-spectrum MMP inhibitor did not. Similarly, administration of rmTIMP-1 to A2B5+immunopanned oligodendrocyte progenitors significantly increased the number of differentiated O1+oligodendrocytes, while antisera to TIMP-1 reduced oligodendrocyte numbers. We also determined that A2B5+oligodendrocyte progenitors grown in conditioned media derived from TIMP-1 KO primary glial cultures resulted in reduced differentiation of mature O1+oligodendrocytes. Finally, we report that addition of rmTIMP-1 to primary glial cultures resulted in a dose-dependent proliferative response of astrocytes. Together, these findings describe a previously uncharacterized role for TIMP-1 in the regulation of oligodendrocytes and astrocytes during development and provide a novel function for TIMP-1 on myelination in the developing CNS.

21 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CWCory M. Willis
Cory M. Willis
ANAlexandra M. Nicaise
Alexandra M. Nicaise
EBErnesto R. Bongarzone
Ernesto R. Bongarzone
MGMaria Givogri
Maria Givogri
CRCory R. Reiter
Cory R. Reiter
SCStephen Crocker
Stephen Crocker
The aging brain is associated with significant changes in physiology that alter the tissue microenvironment of the central nervous system (CNS). In the aged CNS, increased demyelination has been associated with astrocyte hypertrophy and aging has been implicated as a basis for these pathological changes. Aging tissues accumulate chronic cellular stress, which can lead to the development of a pro-inflammatory phenotype that can be associated with cellular senescence. Herein, we provide evidence that astrocytes aged in culture develop a spontaneous pro-inflammatory and senescence-like phenotype. We found that extracellular vesicles (EVs) from young astrocyte were sufficient to convey support for oligodendrocyte differentiation while this support was lost by EVs from aged astrocytes. Importantly, the negative influence of culture age on astrocytes, and their cognate EVs, could be countered by treatment with rapamycin. Comparative proteomic analysis of EVs from young and aged astrocytes revealed peptide repertoires unique to each age. Taken together, these findings provide new information on the contribution of EVs as potent mediators by which astrocytes can extert changing influence in either the disease or aged brain.

22 July 2013 in Brain Sciences
Verified
Journal Article
Open access
PDF file
KCKumiko I. Claycomb
Kumiko I. Claycomb
KJKasey M. Johnson
Kasey M. Johnson
PWPaige N. Winokur
Paige N. Winokur
ASAnthony V. Sacino
Anthony V. Sacino
SCStephen Crocker
Stephen Crocker
Astrocytes regulate fundamentally important functions to maintain central nervous system (CNS) homeostasis. Altered astrocytic function is now recognized as a primary contributing factor to an increasing number of neurological diseases. In this review, we provide an overview of our rapidly developing understanding of the basal and inflammatory functions of astrocytes as mediators of CNS responsiveness to inflammation and injury. Specifically, we elaborate on ways that astrocytes actively participate in the pathogenesis of demyelinating diseases of the CNS through their immunomodulatory roles as CNS antigen presenting cells, modulators of blood brain barrier function and as a source of chemokines and cytokines. We also outline how changes in the extracellular matrix can modulate astrocytes phenotypically, resulting in dysregulation of astrocytic responses during inflammatory injury. We also relate recent studies describing newly identified roles for astrocytes in leukodystrophies. Finally, we describe recent advances in how adapting this increasing breadth of knowledge on astrocytes has fostered new ways of thinking about human diseases, which offer potential to modulate astrocytic heterogeneity and plasticity towards therapeutic gain. In summary, recent studies have provided improved insight in a wide variety of neuroinflammatory and demyelinating diseases, and future research on astrocyte pathophysiology is expected to provide new perspectives on these diseases, for which new treatment modalities are increasingly necessary.

1 February 2017 in Experimental Neurology
Verified
Journal Article
Closed access
ANAlexandra M. Nicaise
Alexandra M. Nicaise
EBErin Banda
Erin Banda
RGRosa M. Guzzo
Rosa M. Guzzo
KRKristen Russomanno
Kristen Russomanno
WCWanda Castro-Borrero
Wanda Castro-Borrero
SCStephen Crocker
Stephen Crocker